Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Supreme Court turns away challenge to U.S. vaccine rule for health workers

Published 10/03/2022, 09:56 AM
Updated 10/03/2022, 12:21 PM
© Reuters. FILE PHOTO: Healthcare workers leave on the METRORail following a shift change as the Omicron variant of the coronavirus continues to spread through the country in Houston, Texas, U.S., December 29, 2021.  REUTERS/Callaghan O'Hare

By Andrew Chung

WASHINGTON (Reuters) -The U.S. Supreme Court on Monday declined to hear a challenge by Missouri and nine other states - mostly Republican-led - to President Joe Biden's COVID-19 vaccine mandate for workers in healthcare facilities that receive federal funds.

The justices turned away an appeal by the states after a lower court declined to immediately consider their claims that the vaccine rule violates federal administrative law and tramples over powers reserved for the states under the U.S. Constitution. The Democratic president's administration issued the rule in November 2021.

The Supreme Court ruled in a 5-4 decision in January to let Biden enforce the healthcare worker mandate while litigation on its legal merits continued in lower courts. The justices at the same time decided 6-3 to halt his administration's rule requiring vaccines or weekly COVID-19 tests for employees at businesses with at least 100 employees.

Biden's administration had argued that the two mandates would save lives and strengthen the U.S. economy by increasing the number of vaccinated Americans. The United States leads the world in COVID-19 deaths, reporting more than a million since the pandemic took hold in the early months of 2020.

The federal healthcare worker rule requires vaccination for about 10.3 million workers at 76,000 healthcare facilities including hospitals and nursing homes that accept money from the Medicare and Medicaid government health insurance programs for elderly, disabled and low-income Americans.

The Supreme Court in January concluded that Biden's regulation fit within the power Congress conferred on the federal government to impose conditions on Medicaid and Medicare funds. It decided that ensuring that medical providers take steps to avoid transmitting a dangerous virus to their patients is consistent with the "fundamental principle of the medical profession: first, do no harm."

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Missouri sued alongside Nebraska, Alaska, Arkansas, Iowa, Kansas, New Hampshire, North Dakota, South Dakota and Wyoming - winning an injunction against the requirement in those states.

The mandate had also been blocked in 15 other states, including Arizona and Texas, following litigation there.

After the justices in January stayed preliminary injunctions issued by lower courts against the rule, including in Missouri's lawsuit, the state asked the St. Louis-based 8th U.S. Circuit Court of Appeals to expedite hearing the merits of the case.

In April, the 8th Circuit instead sent the case back to a federal judge to proceed to a trial. Missouri then appealed to the Supreme Court, contending that the mandate violates federal administrative law and tramples over powers reserved to the states under the Constitution.

Latest comments

bs
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.